M A Afzal

Summary

Affiliation: National Institute for Biological Standards and Control
Country: UK

Publications

  1. ncbi Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Herts, United Kingdom
    J Med Virol 70:171-6. 2003
  2. ncbi Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, United Kingdom
    J Med Virol 78:623-30. 2006
  3. ncbi RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Herts, United Kingdom
    J Med Virol 52:349-53. 1997
  4. ncbi Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Blanch Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    J Virol Methods 126:149-56. 2005
  5. ncbi Vaccines, Crohn's disease and autism
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Herts EN6 3QG, UK
    Mol Psychiatry 7:S49-50. 2002
  6. ncbi Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
    J Med Virol 62:377-82. 2000
  7. ncbi Absence of chicken myelin basic protein residues in commercial formulations of MMR vaccine
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Blanche Lane, Potters Bar, EN6 3QG, Hertfordshire, UK
    Vaccine 19:442-6. 2000
  8. ncbi Clinical safety issues of measles, mumps and rubella vaccines
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Hertfordshire, England
    Bull World Health Organ 78:199-204. 2000
  9. ncbi Evaluation of the neurovirulence test for mumps vaccines
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, U K
    Biologicals 27:43-9. 1999
  10. ncbi Comparative evaluation of measles virus specific TaqMan PCR and conventional PCR using synthetic and natural RNA templates
    L C Ozoemena
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
    J Med Virol 73:79-84. 2004

Collaborators

Detail Information

Publications13

  1. ncbi Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Herts, United Kingdom
    J Med Virol 70:171-6. 2003
    ..A correlation between real-time quantitative PCR and the conventional PCR for measles virus is highly desirable...
  2. ncbi Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, United Kingdom
    J Med Virol 78:623-30. 2006
    ..This study failed to substantiate reports of the persistence of measles virus in autistic children with development regression...
  3. ncbi RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Herts, United Kingdom
    J Med Virol 52:349-53. 1997
    ..However, phylogenetic analysis showed that these viruses grouped with two previously identified lineages which were mostly composed of other European mumps virus isolates...
  4. ncbi Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Blanch Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    J Virol Methods 126:149-56. 2005
    ....
  5. ncbi Vaccines, Crohn's disease and autism
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Herts EN6 3QG, UK
    Mol Psychiatry 7:S49-50. 2002
  6. ncbi Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
    J Med Virol 62:377-82. 2000
    ..The study supports previous findings produced by this laboratory and others using highly sensitive measles virus specific PCR diagnostic technology...
  7. ncbi Absence of chicken myelin basic protein residues in commercial formulations of MMR vaccine
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Blanche Lane, Potters Bar, EN6 3QG, Hertfordshire, UK
    Vaccine 19:442-6. 2000
    ..There was no evidence of the presence of MBP components in MMR vaccines or their progenitor vaccine bulks as shown by the reactivity profiles of the antibody preparations against control and test antigens...
  8. ncbi Clinical safety issues of measles, mumps and rubella vaccines
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, Hertfordshire, England
    Bull World Health Organ 78:199-204. 2000
    ....
  9. ncbi Evaluation of the neurovirulence test for mumps vaccines
    M A Afzal
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, U K
    Biologicals 27:43-9. 1999
    ..However, the test was able to distinguish a wild-type strain from the vaccine strains successfully. The ability of the test to discriminate between acceptable and unacceptable seeds requires further examination...
  10. ncbi Comparative evaluation of measles virus specific TaqMan PCR and conventional PCR using synthetic and natural RNA templates
    L C Ozoemena
    Division of Virology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
    J Med Virol 73:79-84. 2004
    ....
  11. ncbi Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of São Paulo, Brazil
    C L S Santos
    Servico de Virologia do Instituto Adolfo Lutz, Sao Paulo, Brazil
    J Med Virol 80:323-9. 2008
    ..The parameters were established by an expert panel in collaboration with the World Health Organization (WHO) in 2005. This information will enhance the mumps virus surveillance program both at the national and global levels...
  12. ncbi Mumps virus reinfection--clinical findings and serological vagaries
    B Crowley
    Liverpool Public Health Laboratory, University Hospital Aintree, Lower Lane, Liverpool L9 7AL
    Commun Dis Public Health 5:311-3. 2002
    ..These findings raise the possibility of emergence of a mutant strain under the selective pressure of immunisation, with limited or no cross protection induced by the vaccine strain...
  13. ncbi Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia
    Yagob Al-Mazrou
    Ministry of Health, Riyadh, Kingdom of Saudi Arabia
    J Trop Pediatr 48:354-8. 2002
    ..Further studies are needed to prove this conclusively...